CBT-I

Every sleep-tracking device that fits on the fingers or wrists can’t read brain waves.

Chronic insomnia is commonly reported in the fast-paced nature of primary care settings.

As reviewed recently in the New York Times (https://www.nytimes.com/wirecutter/reviews/brain-wave-tracking-sleep-wearables/?

As reported by the New York Times (https://www.nytimes.com/2026/04/22/well/mind/medications-dementia-risk-increase.html), there is strong evidence that antihistamines are associated with increased dementia risk.

A recent 2026 study examined the pattern of sedative-hypnotic prescriptions associated with the risk of suicidal behavior among older adults with and without insomnia.

A recent study assessed the relationship between sleep and cognitive performance in over 20,000 middle and older-age adults in China and the United Kingdom who were tracked for 20 years on measures of sleep.

Low-dose amitriptyline (AM) is an off-label treatment in patients with insomnia.

A recent study examined age-related EEG sleep stage alterations in normal subjects whose sleep had been recorded for the first time 40 years ago.

Insomnia in older adults is associated with widespread benzodiazepine (BZD) and benzodiazepine receptor agonist use (BZRA) such as Ambien despite evidence that chronic use of these sleep medications disrupts sleep regulation and cognition.

A new study examined the relationship between sleep and risk of dementia in 4700 participants with a mean age of 74 years who were followed for 5-19 years for development of dementia after their sleep was assessed on measures of insomnia (wake time after…